Octagon Capital Advisors LP 13D and 13G filings for ArriVent BioPharma, Inc. Common Stock:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-10-11 4:02 pm Purchase | 2024-09-30 | 13G | ArriVent BioPharma, Inc. Common Stock AVBP | Octagon Capital Advisors LP | 1,976,387 5.900% | 1,976,387 (New Position) | Filing |